NCT02762656

Brief Summary

The purpose of this study is to evaluate the effectiveness of perioperative Lidocaine intravenous infusion in reducing postoperative pain for spine surgery patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 5, 2016

Completed
27 days until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

May 5, 2016

Status Verified

May 1, 2016

Enrollment Period

1 year

First QC Date

May 3, 2016

Last Update Submit

May 3, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain

    Quality of recovery after surgery will be assessed using Q0R15 questionnaire and analgesic requirement will be monitored using PCA

    24 hours postop

Study Arms (2)

Lidocaine

ACTIVE COMPARATOR

Patients will receive Lidocaine drip during spine surgery

Drug: Lidocaine

Placebo

PLACEBO COMPARATOR

Patients will receive placebo during spine surgery

Drug: Lidocaine

Interventions

Lidocaine drip during surgery

LidocainePlacebo

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • spine surgery with general anesthesia

You may not qualify if:

  • lidocaine allergy
  • hepatic disease
  • dementia or cognitive decline

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheba Medical Center

Ramat Gan, 5262100, Israel

Location

Related Links

MeSH Terms

Conditions

Spinal Diseases

Interventions

Lidocaine

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Central Study Contacts

Vladimir Solovyev, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2016

First Posted

May 5, 2016

Study Start

June 1, 2016

Primary Completion

June 1, 2017

Study Completion

August 1, 2017

Last Updated

May 5, 2016

Record last verified: 2016-05

Locations